Dangos, Brielle Ambere .
HRN: 25-79-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMPICILLIN 1GM (VIAL)
10/17/2024
10/24/2024
IV
320mg
Q6hrs
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes